Il patriarcato di Aquileia: l'evoluzione dei poteri locali (1250 - 1420)

Il connotato signorile dell'aristocrazia friulana sembra generalmente risolversi nell'esercizio di alcune attribuzioni giurisdizionali esercitate su scala territoriale assai ridotta. In realtà il ruolo egemonico della nobiltà "castellana" poggiava in prevalenza sull'elemento patrimoniale, fonte, di per sé, di larghe ramificazioni di sapore clientelare presso la popolazione rurale. Non sempre, per altro, vi fu stretta convergenza territoriale fra diritti di giustizia e patrimonio fondiario; in molti casi quest'ultimo si configurava secondo zone di insistenza che esorbitavano decisamente dai luoghi di radicamento militare e "signorile" . Bertrando respinse l'idea di legittimare senz'altro un disegno distributivo delle influenze inteso nel senso della acquisizione definitiva. Né riteneva si dovesse trattare con la componente aristocratica senza l'intervento di un momento istituzionale in grado di limitarne l'autonomia e di controllarne i comportamenti. Sulla scia degli orientamenti che avevano guidato la politica torriana Bertrando continuò a considerare l'emergenza udinese e la tradizione di servizio dei Savorgnano come un nucleo di potere di straordinaria incidenza per coordinare in senso centralistico il disegno dei poteri locali. Nella ricerca di soluzioni orientate ad incrementare il peso del potere patriarchino nella società friulana, il patriarca privilegiava di norma il momento alto e risolutivo della risorsa politico-militare piuttosto che la progressiva costruzione di una rete di aderenze larga e capillare, ma variamente frammista al sistema delle influenze aristocratiche. Per l'impostazione di fondo, l'intervento bertrandiano doveva scontare, d'altra parte, tutti i rischi connessi ad una destabilizzazione radicale delle gerarchie di potere - tanto fra i nobiles quanto fra le comunitates - e l'eventualità di una frattura "critica" con lo schieramento avverso

Novel Targets for Old and Diseased Hearts

In this Special Issue we cover a selection of original articles and reviews devoted to the definition of novel molecular targets in cardiovascular diseases, which not only deepen our knowledge on the pathogenesis of the diseases under study, but potentially pave the way to novel diagnostic tools and therapeutic approaches [...]

Ultrafast photodoping and effective Fermi-Dirac distribution of the Dirac particles in Bi2Se3

We exploit time- and angle- resolved photoemission spectroscopy to determine the evolution of the out-of-equilibrium electronic structure of the topological insulator Bi2Se. The response of the Fermi-Dirac distribution to ultrashort IR laser pulses has been studied by modelling the dynamics of the hot electrons after optical excitation. We disentangle a large increase of the effective temperature T* from a shift of the chemical potential mu*, which is consequence of the ultrafast photodoping of the conduction band. The relaxation dynamics of T* and mu* are k-independent and these two quantities uniquely define the evolution of the excited charge population. We observe that the energy dependence of the non-equilibrium charge population is solely determined by the analytical form of the effective Fermi-Dirac distribution.Comment: 5 Pages, 3 Figure

Endothelial cell-cardiomyocyte crosstalk in heart development and disease

The crosstalk between endothelial cells and cardiomyocytes has emerged as a requisite for normal cardiac development, but also a key pathogenic player during the onset and progression of cardiac disease. Endothelial cells and cardiomyocytes are in close proximity and communicate through the secretion of paracrine signals, as well as through direct cell-to-cell contact. Here, we provide an overview of the endothelial cell-cardiomyocyte interactions controlling heart development and the main processes affecting the heart in normal and pathological conditions, including ischaemia, remodelling and metabolic dysfunction. We also discuss the possible role of these interactions in cardiac regeneration and encourage the further improvement of in vitro models able to reproduce the complex environment of the cardiac tissue, in order to better define the mechanisms by which endothelial cells and cardiomyocytes interact with a final aim of developing novel therapeutic opportunities

Mycochemical study of polysaccharides from the edible mushroom Cortinarius caperatus (Gypsy mushroom)

Among basidiomycete molecules, cell wall polysaccharides have been recognized as a major class of bioactive constituents. [1] They are safe molecules and they have a wide spectrum of biological activities, such as immunostimulatory and antioxidant, therefore they possess a prominent role in health benefits coming from mushroom consumption. These properties make mushroom polysaccharides potential candidates for nutraceutical applications and bioactive ingredients production. [2] Fractionation of the hot aqueous extract of Cortinarius caperatus led to isolation of two fractions characterized by spectroscopic analyses (1H-NMR, 13C-NMR, DEPT, 1H-1H COSY, DQCOSY, TOCSY, HSQC, HMBC and HMQC), mass spectrometry (EI-MS, ESI-MS), infrared spectroscopy (FT-IR), chemical reactions of hydrolysis and derivatization followed by GC and HPLC analyses. [3] This mycochemical study revealed a water-soluble fraction characterized as a \u3b2-(1\uf0e06)-D-glucan, whose presence inside C. caperatus has never, to the best of our knowledge, been reported before. Moreover, a water insoluble fraction purified has been characterized as a branched \uf061, (1\u21926) glucan which structure is assumed to be: [\u21926)-\u3b2-D-Glcp(1\u21926)]4-\u3b1-D-Glcp(1\u21924)-\u3b2-D-Glcp(1\u2192 6 \u2191 1 \u3b1-D-Glcp The antioxidant activity of the soluble polysaccharide fraction has been evaluated as radical-scavenging activity with the DPPH test, the \u3b2-(1\uf0e06)-D-glucan showed significative antioxidant activity

A New Bi-Functional Derivative of Polyethylene Glycol as Molecular Carrier for Eugenol and Ibuprofen

Eugenol (EU) and ibuprofene (IBU) were covalently bound to a bi-functionalized PEG, used as molecular carrier of drugs and the release kinetics of the two bioactive molecules was studied in vitro in buffer solution at pH 7.4, in simulated gastric fluid and in mouse plasma. The hydrolysis studies showed a specific cleavage dependent on the pH of the medium and by the presence of proteolytic enzymes in mouse plasma. Studies in vitro on the release of the parent drug from this double prodrug in various media, indicate that the adduct may be sufficiently stable to pass intact the gastrointestinal tract and release into the circulation EU and IBU. Many advantages may be achieved by the synthesis of the prodrug EU-PEG-IBU related to synergistic analgesic and anti-inflammatory effects, to the reduction of the adverse reactions and the improvement of the chemical-physical properties of the parent drugs

Multimeric, Multifunctional Derivatives of Poly(ethylene glycol)

Abstract: This article reviews the use of multifunctional polymers founded on high-molecular weight poly(ethylene glycol) (PEG). The design of new PEG derivatives assembled in a dendrimer-like multimeric fashion or bearing different functionalities on the same molecule is described. Their use as new drug delivery systems based on the conjugation of multiple copies or diversely active drugs on the same biocompatible support is illustrated. Keywords: poly(ethylene glycol); multifunctional polymers; conjugation; drug delivery 1. Introduction For the application of biopharmaceuticals in human therapy, the covalent coupling of poly(ethylene glycol) (PEG) chains to drugs, or PEGylation, has been an outstanding innovation. Important pioneering work in this field was performed by Davis and Abuchowski, laying the cornerstone for the commercial success of this technology [1]. Even though many attempts have been undertaken to develop new polymers with improved properties, none of these new substances have been able to compete with poly(ethylene glycol) for this application. This can be explained by the biocompatibility of PEG and the good experience with PEG as a low-cost additive for the pharmaceutical and cosmetic industry over the last decades. An ideal PEG reagent fulfills at least the following criteria: (a)